FindTrial
Sign In

Dynamical trajectory of glucocorticoids tapering and discontinuation in children with ITP in a real-world setting

Dynamical trajectory of glucocorticoids tapering and discontinuation in children with ITP in a real-world setting

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055472
Enrollment
Unknown
Registered
2022-01-10
Start date
2022-02-01
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune Thrombocytopenia (ITP)

Interventions

Normal withdrawal group:none
Delayed discontinuation group:none

Sponsors

Children's Hospital Affiliated to Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. According to the diagnosis and treatment of primary immune thrombocytopenia in children (2019 edition), the diagnosis is confirmed as primary ITP, excluding secondary ITP and other congenital and tumor thrombocytopenia; 2. Aged 1 month - 18 years; 3. Diagnosis time: January 2010 to December 2020; 4. Follow-up for more than 1 year, and at least 3 follow-ups.

Exclusion criteria

Exclusion criteria: 1. There is no curative effect index; 2. Concurrently suffer from other diseases that may affect hormone reduction (such as systemic lupus erythematosus).

Design outcomes

Primary

MeasureTime frame
platelet count;—

Countries

China

Contacts

Public ContactXiao Li

Children's Hospital Affiliated to Chongqing Medical University

254606573@qq.com+86 15823373609

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026